Katarzyna Kolossa

Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis

Jerzy Świerkot, Katarzyna Bogunia‐Kubik, Beata Nowak et al. · Joint Bone Spine · 2014 · 51 citations

Life Sciences, Genetics, Immunology +17

Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy

Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa et al. · Clinical & Experimental Immunology · 2015 · 32 citations · Full text

Life Sciences, Genetics, Immunology +17

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients

Milena Iwaszko, Joanna Wielińska, Jerzy Świerkot et al. · Frontiers in Immunology · 2021 · 31 citations · Full text

Medicine, Genetics, Immunology +13

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis

Milena Iwaszko, Jerzy Świerkot, Katarzyna Kolossa et al. · Genes · 2018 · 27 citations · Full text

Life Sciences, Genetics, Immunology +17

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.

Ryszard Wiacek, Katarzyna Kolossa, Tomasz Jankowski et al. · PubMed · 2013 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +15